China has embraced a vigorously growing healthcare market in the past decade. Ever since joining ICH in 2017, China has seen increased clinical trials and accelerated new drug and device approval. For biotech and medtech companies outside of China, you need to find the right partners and the right resources to bring your products to China, in order to adapt to difference in culture, regulation, reimbursement, etc. In the meantime, Chinese biotechs are actively seeking global market entry opportunities and oversea partners.
China Focus @San Francisco is a partnering forum designed to provide a meaningful platform to inform, inspire, and foster cross-border partnership in life science and healthcare.